Question 1

What is the catalog number for 2- (2',3',4'-Trihydroxybutyl) quinoxaline?

Accepted Answer

The catalog number for 2- (2',3',4'-Trihydroxybutyl) quinoxaline is FT28497.

Question 2

What sizes are available for 2- (2',3',4'-Trihydroxybutyl) quinoxaline?

Accepted Answer

2- (2',3',4'-Trihydroxybutyl) quinoxaline is available in the following size(s): 5 mg, 10 mg, 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does 2- (2',3',4'-Trihydroxybutyl) quinoxaline come in?

Accepted Answer

2- (2',3',4'-Trihydroxybutyl) quinoxaline is available in 5 different pack sizes.

Question 4

Is 2- (2',3',4'-Trihydroxybutyl) quinoxaline in stock?

Accepted Answer

2- (2',3',4'-Trihydroxybutyl) quinoxaline is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Question 6

How many freeze-thaw cycles can this product tolerate?

Accepted Answer

We recommend aliquoting the product upon receipt to avoid repeated freeze-thaw cycles, which can reduce activity and stability. This is your responsibility once the product has been delivered.

Question 7

Is antigen retrieval required for IHC with this antibody?

Accepted Answer

Recommended antigen retrieval methods, where applicable, are listed on the datasheet under the IHC protocol section.

2- (2',3',4'-Trihydroxybutyl) quinoxaline

Product Specifications

CAS Number

Synonyms

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Available Sizes

Frequently Asked Questions

Explore Other Products

Human MICALL2 activation kit by CRISPRa

Human RBM26 activation kit by CRISPRa

CMV TaqMan PCR Kit

PE/Cyanine5.5 Rat IgG2a, κ Isotype Control[2A3]

PE/Cyanine5.5 Rat IgG2a, κ Isotype Control[2A3]

PE/Cyanine5.5 Rat IgG2a, κ Isotype Control[2A3]